JULIA ŚWIECHOWSKA et al. MID-REGIONAL PRO-ADRENOMEDULLIN (MR-proADM) AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN EARLY SEPSIS: A NARRATIVE REVIEW. International Journal of Innovative Technologies in Social Science, [S. l.], v. 2, n. 2(50), 2026. DOI: 10.31435/ijitss.2(50).2026.5741. Disponível em: https://rspublisher.org/index.php/ijitss/article/view/5741. Acesso em: 15 jun. 2026.